MJ is now into the MJ sector, and there's no turning back! With a relatively small float (most MJ plays have a billion or so shares out), their CEO is one of the best in the bunch, and if he plays his cards right, he'll take Inergetics to the top, and the shareholders along with it.
I think once investors go through the recent FINS of NRTI, they'll notice the difference between the management here and elsewhere. There are no taxi drivers here (LOL), and the pinksheet status is somewhat misleading, as it reflects past poor decisions on behalf of management, and their inability to turn the company into something profitable. The CEO is also against promoting the stock, so meaningless PRs aren't put out like most of the others.
Also, it's quite reasonable to assume that this partnership will announce a product line within a short period of time and have PR surrounding it's inception, and any additional deals that are struck. That may catch some off guard that are expecting that it could be a year or so away and that NRTI isn't a true player. It may also catch folks off guard if the CEO is able to pull some of the same strings he did with the MSE brand in terms of distribution. Unlike before, however, he'll have the entire MJ sector of traders/investors following the news releases that are put out.
Maxim and other MMs will have a tough time, IMO, trying to keep NRTI down from here on out. MJ investors and traders are always looking for the next big thing, and unlike the others, there's solid management with this one, and as mentioned by some already, they have other product lines in place that have their own potential. They may be early stage, but things could move rapidly, just as they have with their flagship product line, MSE.
I'm still not sold on MSE due to the expenses, but when you stop and look at how much the CEO has done in so little time, you have to give the man credit for his hard and tireless work in building a brand. There's no doubt in my mind that the same hard work he's put into expanding the MSE brand, he'll put into the one that will shortly be announced to the MJ world. Mr James is also the type of CEO that would be perfect for an interview on CNBC, and we all know what can happen when CNBC starts mentioning a particular stock in the MJ sector.
Time will tell as always, but the potential here is only growing. Unlike before, however, he'll have thousands, if not tens of thousands of folks watching his small biotech company. If that's not the case now, then it will be. Of that, I have no doubt. Like I said, I think many folks could get caught off guard with how swiftly the ball could get rolling with NRTI. If that's the case, and it starts to selloff, then indeed I plan on buying more shares at cheaper prices.
AI
